Overview

Study of Fat Malabsorption by Lipiblock Versus Xenical

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Obesity is a chronic condition with fat-rich diets playing a major role in its etiology. Pharmacological therapy has been proposed for weight loss and maintenance. This study aims to study the intestinal lipase blockade by partial inhibition of fat absorption after treatment with two commercials formulations of Orlistat.
Phase:
N/A
Details
Lead Sponsor:
University of Campinas, Brazil
Collaborator:
Germed Pharma
Treatments:
Orlistat